Needham & Company reiterated a Buy rating and $28.00 price target on HealthStream (NASDAQ: HSTM) following the company's 4Q earnings ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View

Cantor Fitzgerald Reiterates Neutral Rating and $27 PT on HealthStream (HSTM) Following 'Light' 4Q16 ResultsFebruary 22, 2017 6:52 AM HealthStream (HSTM) Misses Q4 EPS by 5cFebruary 21, 2017 4:32 PM HealthStream Announces Fourth Quarter & Full Year 2016 ResultsFebruary 21, 2017 4:30 PM